Onyx Pharmaceuticals (ONXX +4.3%) moves higher in the wake of the failure of Bristol-Myers' (BMY -0.2%) experimental drug brivanib to improve survival in liver cancer patients in a late-stage clinical trial. The result is seen as reducing the competitive risk for ONXX's Nexavar, the only drug approved for liver cancer and a key contributor to the company's revenue and valuation. [View news story]
likely a short-lived pop for $ONXX. nexavar is very difficult to tolerate and 3 more trials with $BMY brivanib continue. not time to count $BMY out.
Energy Investors: 2 New Ways to Profit From the Middle East Uprising [View article]
i like SU & CNQ. but wouldn't touch anything from Yemen. there's no way to research it. plus, Yemen is next in line looking down the barrel of upheaval.
And just like that, the Dow's triple-digit advance is gone. Dow now just into the negative, -1.74 to 10,364.41. S&P 500 dives, down 0.2% to 1,099.57, and Nasdaq on its way, now down 0.2% to 2,170. Basic materials, especially miners and metals, have been the drag so far. [View news story]
greedy folks on wallstreet want it both ways right now. they want equities to keep appreciating but don't want higher interest rates. at some point that will be a fact of life. but i'm convinced they are addicted to easy monetary policy from the FED.
whether you like them or not, this is what the "bond kings" at pimco contend - the market is still on a sugar high. pimco is probably selling bonds and the market right now as far as i'm concerned. i have no material evidence of this, just a hunch.
the dubai debt fears are rolling this way. reminiscent of late feb-2007 with fears over asia. that event essentially marked the beginning of the tsunami that finished in mar-2009. here we go again.
The bond market swallowed billions more in Treasurys today with little ill effect on prices, and more sales to come this week. The 30-year yield +0.01 to 4.41%; 10-year -0.01 to 3.47%; 5-year -0.01 to 2.29%; 2-year -0.02 to 0.84%. Dollar +0.1% against euro; +0.2% against pound; -0.1% against yen. [View news story]
it's incredible how these bonds keep getting gobbled up. you'd think it was thanksgiving or something. oh! yeah! :)
The Treasury expects to borrow $276B in the fourth quarter - $209B lower than it estimated in August. The number compares to $393B borrowed in the third quarter, and an expected $478B for the first quarter of 2010. Today, Treasurys are moving lower: the 30-year yield now +0.04 to 4.27%; 10-year +0.04 to 3.42%; 5-year +0.02 to 2.33%; 2-year +0.02 to 0.92%. [View news story]
$478B in Q1-2010? yikes!!! must be expecting the dollar to devalue even more?
Why You Shouldn't Hold Leveraged ETFs Long-Term [View article]
jim, type "levered ETF", "leveraged ETF" or "inverse ETF" in the search field. i don't believe there's been serious discourse about this topic here for 6 or 7 mons or more.
Bonds headed still higher, with the 30-year yield -0.10 to 4.24%; 10-year -0.10 to 3.39%; 5-year -0.12 to 2.32%; 2-year -0.08 to 0.90%. Dollar +0.7% against euro, +0.6% against pound, -1.5% against yen. [View news story]
the bond market rally today is good for the market overall. folks are still putting money to work other than in money markets or savings accounts.
Traders Intuition: Market Euphoria About to Come Crashing Down [View article]
about to meaning in 6 -10 more weeks. there's a scarcity in unrealized profits. that scarcity will be satisfied toward year end. soon after which is when to look for a "major" sell-off.
Onyx Pharmaceuticals (ONXX +4.3%) moves higher in the wake of the failure of Bristol-Myers' (BMY -0.2%) experimental drug brivanib to improve survival in liver cancer patients in a late-stage clinical trial. The result is seen as reducing the competitive risk for ONXX's Nexavar, the only drug approved for liver cancer and a key contributor to the company's revenue and valuation. [View news story]
Energy Investors: 2 New Ways to Profit From the Middle East Uprising [View article]
Muni Bond ETFs in Freefall [View article]
Seven ETFs to Invest Like Peter Schiff [View article]
And just like that, the Dow's triple-digit advance is gone. Dow now just into the negative, -1.74 to 10,364.41. S&P 500 dives, down 0.2% to 1,099.57, and Nasdaq on its way, now down 0.2% to 2,170. Basic materials, especially miners and metals, have been the drag so far. [View news story]
whether you like them or not, this is what the "bond kings" at pimco contend - the market is still on a sugar high. pimco is probably selling bonds and the market right now as far as i'm concerned. i have no material evidence of this, just a hunch.
Seeking Alpha Completes Series B Funding Round [View instapost]
Bond Expert: I'm Moving On, With Thanks [View article]
Toward Economic Recovery in Dubai [View article]
The bond market swallowed billions more in Treasurys today with little ill effect on prices, and more sales to come this week. The 30-year yield +0.01 to 4.41%; 10-year -0.01 to 3.47%; 5-year -0.01 to 2.29%; 2-year -0.02 to 0.84%. Dollar +0.1% against euro; +0.2% against pound; -0.1% against yen. [View news story]
Bond Expert: Wednesday Outlook [View article]
made sense to me. -cheers!
The Treasury expects to borrow $276B in the fourth quarter - $209B lower than it estimated in August. The number compares to $393B borrowed in the third quarter, and an expected $478B for the first quarter of 2010. Today, Treasurys are moving lower: the 30-year yield now +0.04 to 4.27%; 10-year +0.04 to 3.42%; 5-year +0.02 to 2.33%; 2-year +0.02 to 0.92%. [View news story]
Why You Shouldn't Hold Leveraged ETFs Long-Term [View article]
Bonds headed still higher, with the 30-year yield -0.10 to 4.24%; 10-year -0.10 to 3.39%; 5-year -0.12 to 2.32%; 2-year -0.08 to 0.90%. Dollar +0.7% against euro, +0.6% against pound, -1.5% against yen. [View news story]
Nasdaq Breaks 50-DMA, S&P on the Brink [View article]
Traders Intuition: Market Euphoria About to Come Crashing Down [View article]